<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03403842</url>
  </required_header>
  <id_info>
    <org_study_id>125/INT/2017</org_study_id>
    <nct_id>NCT03403842</nct_id>
  </id_info>
  <brief_title>Acute Post-operative Pain in Colon Resections</brief_title>
  <acronym>ERAS-PO</acronym>
  <official_title>Treatment of Acute Post-operative Pain in Patients Undergoing Laparoscopic Colon Resections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>IRCCS San Raffaele</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>IRCCS San Raffaele</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective of the study is to compare three different analgesic techniques in patients
      undergoing laparoscopic colon resections: peridural catheter, patient controlled analgesia of
      endovenous morphine and patient controlled analgesia of sufentanil sublingual tablets.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      159 patients undergoing laparoscopic colon resections will be enrolled and randomized in
      three different groups.

      Patients in the first group will be subjected to the positioning of a peridural catheter with
      a continuous infusion of ropivacaine 0,2%99 ml+sufentanil 50 mcg at an infusion rate of 4-6
      ml/h.

      In the second group participants will receive an intraoperative bolus of morphine (0,05mg/kg)
      and post-operatively a patient controlled analgesia of endovenous morphine (injection dose 1
      mg,lock-out 10 minutes,maximum morphine dosage for hour 4 mg).

      In the third group the investigators will adopt an intraoperative bouls of morphine
      (0,05mg/kg) and post-operatively a patient controlled analgesia of sufentanil sublingual
      tablets( 15 mcg, lock-out 20 minutes)
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">February 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain intensity change in the post-operative period depending on the adopted analgesic treatment</measure>
    <time_frame>NRS will be evaluated in recovery room at 30 minutes after the end of surgery and at 6-24-48-72 hours after the end of surgery or until to the end of the proposed analgesic treatment</time_frame>
    <description>The intensity of acute post-operative pain will be evaluated ,according NRS(numerical rating scale) by our Acute pain Service.NRS is a 11 point scale for patient self-reporting of pain, where zero represents no pain and ten is considered as the worst pain ever possible</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Side effects</measure>
    <time_frame>The onset of possible side effects will be monitored from randomization until to the end of the proposed analgesic treatment, assessed up to 72 hours</time_frame>
    <description>Evaluation of possible side effects according to the technique adopted</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">159</enrollment>
  <condition>Analgesia</condition>
  <arm_group>
    <arm_group_label>PERIDURAL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Peridural catheter positioning with a continuous infusion of ropivacaine 0,2% 99 ml+ sufentanil 50 mcg at an infusion rate of 4-6 ml/h</description>
  </arm_group>
  <arm_group>
    <arm_group_label>PCA MORPHINE</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patient controlled analgesia of endovenous morphine, injection dose 1 mg, lock-out time 10 minutes, maximum dosage for hour 4 mg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>SSTS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients controlled analgesia of sublingual sufentanil tablet system, 15 mcg sufentanil tablets, lock out time 20 minutes</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sublingual sufentanil tablet system</intervention_name>
    <description>Administration of sublingual sufentanil with a PCA</description>
    <arm_group_label>SSTS</arm_group_label>
    <other_name>Zalviso</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Peridural catheter</intervention_name>
    <description>Positioning of a peridural catheter with a continuous infusion of ropivacaine 0,2% 99 ml+sufentanil 50 mcg</description>
    <arm_group_label>PERIDURAL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>PCA Morphine</intervention_name>
    <description>Administration of endovenous morphine with a PCA</description>
    <arm_group_label>PCA MORPHINE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age&gt;18 Patients undergoing laparoscopic colon resections/ Acceptance informed consent

        Exclusion Criteria:

          -  Contraindications to the positioning of a peridural catheter/ Previous allergic
             reactions to the drugs used in the study/ inability of using patient controlled
             analgesia system
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>stefano turi, md</last_name>
    <phone>0226432656</phone>
    <email>turi.stefano@hsr.it</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>marco gemma, md</last_name>
    <phone>0226432656</phone>
    <email>gemma.marco@hsr.it</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>S. Raffaele Hospital</name>
      <address>
        <city>Milano</city>
        <state>MI</state>
        <zip>20132</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marco Gemma, MD</last_name>
      <phone>++390226432656</phone>
      <email>gemma.marco@hsr.it</email>
    </contact>
    <investigator>
      <last_name>stefano turi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Feldheiser A, Aziz O, Baldini G, Cox BP, Fearon KC, Feldman LS, Gan TJ, Kennedy RH, Ljungqvist O, Lobo DN, Miller T, Radtke FF, Ruiz Garces T, Schricker T, Scott MJ, Thacker JK, Ytrebø LM, Carli F. Enhanced Recovery After Surgery (ERAS) for gastrointestinal surgery, part 2: consensus statement for anaesthesia practice. Acta Anaesthesiol Scand. 2016 Mar;60(3):289-334. doi: 10.1111/aas.12651. Epub 2015 Oct 30. Review.</citation>
    <PMID>26514824</PMID>
  </reference>
  <reference>
    <citation>Borzellino G, Francis NK, Chapuis O, Krastinova E, Dyevre V, Genna M. Role of Epidural Analgesia within an ERAS Program after Laparoscopic Colorectal Surgery: A Review and Meta-Analysis of Randomised Controlled Studies. Surg Res Pract. 2016;2016:7543684. doi: 10.1155/2016/7543684. Epub 2016 Aug 24. Review.</citation>
    <PMID>27642630</PMID>
  </reference>
  <reference>
    <citation>Hübner M, Blanc C, Roulin D, Winiker M, Gander S, Demartines N. Randomized clinical trial on epidural versus patient-controlled analgesia for laparoscopic colorectal surgery within an enhanced recovery pathway. Ann Surg. 2015 Apr;261(4):648-53. doi: 10.1097/SLA.0000000000000838.</citation>
    <PMID>25119117</PMID>
  </reference>
  <reference>
    <citation>Gustafsson UO, Scott MJ, Schwenk W, Demartines N, Roulin D, Francis N, McNaught CE, MacFie J, Liberman AS, Soop M, Hill A, Kennedy RH, Lobo DN, Fearon K, Ljungqvist O; Enhanced Recovery After Surgery Society. Guidelines for perioperative care in elective colonic surgery: Enhanced Recovery After Surgery (ERAS®) Society recommendations. Clin Nutr. 2012 Dec;31(6):783-800. doi: 10.1016/j.clnu.2012.08.013. Epub 2012 Sep 28. Review.</citation>
    <PMID>23099039</PMID>
  </reference>
  <reference>
    <citation>Charlton S, Cyna AM, Middleton P, Griffiths JD. Perioperative transversus abdominis plane (TAP) blocks for analgesia after abdominal surgery. Cochrane Database Syst Rev. 2010 Dec 8;(12):CD007705. doi: 10.1002/14651858.CD007705.pub2. Review.</citation>
    <PMID>21154380</PMID>
  </reference>
  <reference>
    <citation>Ljungqvist O, Scott M, Fearon KC. Enhanced Recovery After Surgery: A Review. JAMA Surg. 2017 Mar 1;152(3):292-298. doi: 10.1001/jamasurg.2016.4952. Review.</citation>
    <PMID>28097305</PMID>
  </reference>
  <reference>
    <citation>Frampton JE. Sublingual Sufentanil: A Review in Acute Postoperative Pain. Drugs. 2016 Apr;76(6):719-29. doi: 10.1007/s40265-016-0571-6. Review.</citation>
    <PMID>27067596</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 29, 2017</study_first_submitted>
  <study_first_submitted_qc>January 17, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 19, 2018</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>IRCCS San Raffaele</investigator_affiliation>
    <investigator_full_name>Marco Gemma</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Morphine</mesh_term>
    <mesh_term>Sufentanil</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

